Loading headlines…
Collected headline brief
The UK's MHRA has approved the first GLP-1 receptor agonist tablet for weight loss, offering a more convenient alternative to weekly injections. Semaglutide, branded as Wegovy, is now available in pill form for adults with obesity or those…
Complete reading on newsGlobal
Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →There is more to this story